|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ebina Y, Yaegashi N, Katabuchi H, Nagase
S, Udagawa Y, Hachisuga T, Saito T, Mikami M, Aoki Y and Yoshikawa
H: Japan Society of Gynecologic Oncology guidelines 2011 for the
treatment of uterine cervical cancer. Int J Clin Oncol. 20:240–248.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
National comprehensive cancer network, .
NCCN clinical practice guidelines in oncology-cervical
cancer-version II. 2013.
|
|
5
|
Morris M, Eifel PJ, Lu J, Grigsby PW,
Levenback C, Stevens RE, Rotman M, Gershenson DM and Mutch DG:
Pelvic radiation with concurrent chemotherapy compared with pelvic
and para-aortic radiation for high-risk cervical cancer. N Engl J
Med. 340:1137–1143. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eifel PJ, Winter K, Morris M, Levenback C,
Grigsby PW, Cooper J, Rotman M, Gershenson D and Mutch DG: Pelvic
irradiation with concurrent chemotherapy versus pelvic and
para-aortic irradiation for high-risk cervical cancer: An update of
radiation therapy oncology group trial (RTOG) 90–01. J Clin Oncol.
22:872–880. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishiko O, Sumi T, Yasui T, Matsumoto Y,
Kawamura N, Ogita S, Kamino T, Nakamura K and Yamada R:
Balloon-occluded arterial infusion chemotherapy, simple total
hysterectomy, and radiotherapy as a useful combination-therapy for
advanced cancer of the uterine cervix. Oncol Rep. 7:141–144.
2000.PubMed/NCBI
|
|
8
|
Souhami L, Gil RA, Allan SE, Canary PC,
Araújo CM, Pinto LH and Silveira TR: A randomized trial of
chemotherapy followed by pelvic radiation therapy in stage IIIB
carcinoma of the cervix. J Clin Oncol. 9:970–977. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tattersall MH, Lorvidhaya V, Vootiprux V,
Cheirsilpa A, Wong F, Azhar T, Lee HP, Kang SB, Manalo A, Yen MS,
et al: Randomized trial of epirubicin and cisplatin chemotherapy
followed by pelvic radiation in locally advanced cervical cancer.
Cervical cancer study group of the Asian Oceanian clinical oncology
association. J Clin Oncol. 13:444–451. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ishiko O, Sumi T, Yasui T, Matsumoto Y,
Ogita S, Kaminou T, Nakamura K and Yamada R: Tumor marker and MR
imaging criteria for evaluating the efficacy of cyclic
balloon-occluded arterial infusion for advanced cancer of the
uterine cervix. Oncol Rep. 7:827–830. 2000.PubMed/NCBI
|
|
11
|
Ishiko O, Sumi T, Yoshida H, Ogita S and
Yamada R: Expression of apoptosis regulatory proteins in advanced
cancer of the uterine cervix after cyclic balloon-occluded arterial
infusion chemotherapy. Int J Oncol. 18:1151–1155. 2001.PubMed/NCBI
|
|
12
|
Okamoto E, Sumi T, Misugi F, Nobeyama H,
Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K and Ishiko O:
Expression of apoptosis-related proteins in advanced uterine
cervical cancer after balloon-occluded arterial infusion
chemotherapy as an indicator of the efficiency of this therapy. Int
J Mol Med. 15:41–47. 2005.PubMed/NCBI
|
|
13
|
Nobeyama H, Sumi T, Misugi F, Okamoto E,
Hattori K, Matsumoto Y, Yasui T, Honda K, Iwai K and Ishiko O:
Association of HPV infection with prognosis after neoadjuvant
chemotherapy in advanced uterine cervical cancer. Int J Mol Med.
14:101–105. 2004.PubMed/NCBI
|
|
14
|
Panici P Benedetti, Bellati F, Manci N,
Pernice M, Plotti F, Di Donato V, Calcagno M, Zullo MA, Muzii L and
Angioli R: Neoadjuvant chemotherapy followed by radical surgery in
patients affected by FIGO stage IVA cervical cancer. Ann Surg
Oncol. 14:2643–2648. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pelicano H, Carney D and Huang P: ROS
stress in cancer cells and therapeutic implications. Drug Resist
Updat. 7:97–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alexandre J, Batteux F, Nicco C, Chéreau
C, Laurent A, Guillevin L, Weill B and Goldwasser F: Accumulation
of hydrogen peroxide is an early and crucial step for
paclitaxel-induced cancer cell death both in vitro and in vivo. Int
J Cancer. 119:41–48. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fruehauf JP and Meyskens FL Jr: Reactive
oxygen species: A breath of life or death? Clin Cancer Res.
13:789–794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boss O, Muzzin P and Giacobino JP: The
uncoupling proteins, a review. Eur J Endocrinol. 139:1–9. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fleury C and Sanchis D: The mitochondrial
uncoupling protein-2: Current status. Int J Biochem Cell Biol.
31:1261–1278. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baffy G: Uncoupling protein-2 and cancer.
Mitochondrion. 10:243–252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Echtay KS, Murphy MP, Smith RA, Talbot DA
and Brand MD: Superoxide activates mitochondrial uncoupling protein
2 from the matrix side. Studies using targeted antioxidants. J Biol
Chem. 277:47129–47135. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hoang T, Smith MD and Jelokhani-Niaraki M:
Toward understanding the mechanism of ion transport activity of
neuronal uncoupling proteins UCP2, UCP4, and UCP5. Biochemistry.
51:4004–4014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carretero MV, Torres L, Latasa U,
Garcia-Trevijano ER, Prieto J, Mato JM and Avila MA: Transformed
but not normal hepatocytes express UCP2. FEBS Lett. 439:55–58.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Horimoto M, Resnick MB, Konkin TA,
Routhier J, Wands JR and Baffy G: Expression of uncoupling
protein-2 in human colon cancer. Clin Cancer Res. 10:6203–6207.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Duval C, Nègre-Salvayre A, Dogilo A,
Salvayre R, Pénicaud L and Casteilla L: Increased reactive oxygen
species production with antisense oligonucleotides directed against
uncoupling protein 2 in murine endothelial cells. Biochem Cell
Biol. 80:757–764. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mattiasson G, Shamloo M, Gido G, Mathi K,
Tomasevic G, Yi S, Warden CH, Castilho RF, Melcher T,
Gonzalez-Zulueta M, et al: Uncoupling protein-2 prevents neuronal
death and diminishes brain dysfunction after stroke and brain
trauma. Nat Med. 9:1062–1068. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Teshima Y, Akao M, Jones SP and Marbán E:
Uncoupling protein-2 overexpression inhibits mitochondrial death
pathway in cardiomyocytes. Circ Res. 93:192–200. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pozza E Dalla, Fiorini C, Dando I,
Menegazzi M, Sgarbossa A, Costanzo C, Palmieri M and Donadelli M:
Role of mitochondrial uncoupling protein 2 in cancer cell
resistance to gemcitabine. Biochim Biophys Acta. 1823:1856–1863.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mailloux RJ, Adjeitey CN and Harper ME:
Genipin-induced inhibition of uncoupling protein-2 sensitizes
drug-resistant cancer cells to cytotoxic agents. PLoS One.
5:e132892010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Derdák Z, Fülöp P, Sabo E, Tavares R,
Berthiaume EP, Resnick MB, Paragh G, Wands JR and Baffy G: Enhanced
colon tumor induction in uncoupling protein-2 deficient mice is
associated with NF-kappaB activation and oxidative stress.
Carcinogenesis. 27:956–961. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsuji K, Yamada R, Kawabata M, Mitsuzane
K, Sato M, Iwahashi M, Kitayama S and Nakano R: Effect of balloon
occluded arterial infusion of anticancer drugs on the prognosis of
cervical cancer treated with radiation therapy. Int J Radiat Oncol
Biol Phys. 32:1337–1345. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sinicrope FA, Ruan SB, Cleary KR, Stephens
LC, Lee JJ and Levin B: Bcl-2 and p53 oncoprotein expression during
colorectal tumorigenesis. Cancer Res. 55:237–241. 1995.PubMed/NCBI
|
|
33
|
Collins P, Jones C, Choudhury S, Damelin L
and Hodgson H: Increased expression of uncoupling protein 2 in
HepG2 cells attenuates oxidative damage and apoptosis. Liver Int.
25:880–887. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pozza E Dalla, Fiorini C, Dando I,
Menegazzi M, Sgarbossa A, Costanzo C, Palmieri M and Donadelli M:
Role of mitochondrial uncoupling protein 2 in cancer cell
resistance to gemcitabine. Biochim Biophy Acta. 1823:1856–1863.
2012. View Article : Google Scholar
|
